CAPITOL COUNSEL LLC
Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Represent organizations that promote research and support growth of biotechnology industry
-
KAREN STONE New on this filingPreviously held: Office of former Congressman Steve Israel (D-NY) [Legislative Correspondent/Staff Assistant, 2005; Senior Legislative Assistant, 2005-2009] Office of Congresswoman Dina Titus (D-NV) [Legislative Director, 2009-2010].
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Legislative and regulatory issues affecting innovation, including vaccines.
Issues related to tarriffs.
Items related to USDA, FDA, genetic engineering, and regulations associated with biotechnology in the Agriculture/Rural Development/Food and Drug Administration proposed Appropriation measures for FY 2026 (House/Senate).
Public health issues impacting patient access to treatments. Updates and reforms to regulation of treatment development and research.